Schaeffer's Top Stock Picks for '25

The Biotech Stock Ready to Double in Value

Sohu.com reported impressive second-quarter revenue

Jul 31, 2017 at 9:27 AM
facebook X logo linkedin


The Dow is ready to hit a new high ahead of a busy day of economic data. Electric car manufacturer Tesla Inc (NASDAQ:TSLA), Chinese gaming issue Sohu.com Inc (NASDAQ:SOHU), and biotech Dynavax Technologies Corporation (NASDAQ:DVAX) are three stocks in the news to start the day, for varying reasons. Here's a quick look at what's moving shares of TSLA, SOHU, and DVAX.

Tesla Stock Tries to Rally on Model 3 Buzz

Tesla stock is edging higher in pre-market trading, after CEO Elon Musk on Friday said the company has taken more than 500,000 reservations for its Model 3 vehicle. TSLA closed last week at $335.07, up roughly 57% year-to-date but far removed from its June 23 record high of $386.99. Plus, the stock's 50-day moving average acted as stiff resistance during its last breakout attempt. 

Options traders at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) have continued to bet bullishly, however, with Tesla's 10-day call/put volume ratio coming in at 1.18 -- meaning call buying has outpaced put buying. But premium has spiked on near-term TSLA options since last week, with the equity's Schaeffer's Volatility Index (SVI) of 52% standing as a 52-week high. 

Sohu.com Soars on Strong Sales

Shares of Sohu.com are trading 8% higher in electronic trading, after the company reported better-than-expected second-quarter sales and an upbeat third-quarter outlook. The stock has jumped 29.5% year-over-year to trade at $50.85, and today should reach territory not seen since January 2016. 

If SOHU stock can continue to impress on and off the charts, it could benefit from a round of bullish analyst attention. For instance, the majority of covering brokerage firms currently rate it a "hold" or worse, and the shares are trading above their average 12-month price target of $50.56. This leaves the door open for upgrades and/or price-target increases in the near future. 

Dynavax Set to Double in Value Thanks to Hepatitis B Vaccine

It's shaping up to be an unbelievable day for anyone holding Dynavax Technologies stock. A Food and Drug Administration (FDA) advisory panel voted in favor of the company's hepatitis B vaccine, and now DVAX shares are set to open a whopping 91% higher. They had already more than doubled on a year-to-date basis, settling Friday at $9.25. Analysts are expecting more upside, too. RBC upgraded DVAX to "outperform" from "sector perform" and raised its price target to $26, saying it now sees FDA approval of the vaccine as "highly probable." Meanwhile, Cowen cut its price target to $30 from $45. 
 
 

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

10 Stock Picks FREE
 
 

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade.  Professional traders have rushed into the market and are making a mint.  Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.

 

 
 

FREE Report Download

 

Follow us on X, Follow us on Twitter